CD8A and neoplasm: Recent studies have shown that reactivation of Tex cells can be achieved by blocking PD‐1 or other inhibitory pathways, highlighting a potential avenue for anti‐tumor therapy.[37, 38] Effective CD8+ T cell responses are critical for anti‐tumor immunity, which could explain the observed decrease in tumor volume upon PPY knockdown.